NCT02834013 2026-06-03Nivolumab and Ipilimumab in Treating Patients With Rare TumorsNational Cancer Institute (NCI)Phase 2 Active not recruiting798 enrolled
NCT02402244 2026-05-05Project: Every Child for Younger Patients With CancerChildren's Oncology GroupRecruiting75,000 enrolled